About
Generics & APIs
Areas of Focus
Categories
API FocusedGeneric DrugMiddle East
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
1,095
By Phase
PHASE1/PHASE2: 2PHASE3: 1PHASE2: 1
By Status
COMPLETED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07185815Lead Sponsor
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
PHASE1/PHASE2Recruiting
24 participants
Started: Aug 1, 2025 · Completed: Jun 3, 2027
NCT04121221Lead Sponsor
A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS
PHASE3Completed
1,016 participants
Started: Sep 19, 2019 · Completed: Jun 13, 2023
NCT03362294Lead Sponsor
Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS
PHASE2Active, not recruiting
30 participants
Started: Dec 11, 2017 · Completed: Sep 30, 2026
NCT02212886Lead Sponsor
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS
PHASE1/PHASE2Completed
25 participants
Started: Oct 31, 2014 · Completed: Nov 20, 2024
Locations (1)
Headquarters
Ness Ziona, Israel
Map
Loading map...